Product Information

JASMIEL 3 MG-0.02 MG TABLET is a generic product labeled by Afaxys Pharma, LLC, priced at $0.1956 per EA under NDC 50102024023. Its NADAC has been published 384 times since Jul 10, 2019.

FDA first approved this application on Feb 27, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

JASMIEL 3 MG-0.02 MG TABLET

Drospirenone and Ethinyl Estradiol
$0.1956per EA

Manufacturer

Afaxys Pharma, LLC

NDC

50102024023

Classification

Generic

Dosage Form

KIT

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209632

FDA Approved

2/27/2018

TE Code

AB

On Market Since

2/27/2018

Price Statistics

The NADAC for JASMIEL 3 MG-0.02 MG TABLET has been published 384 times since Jul 10, 2019, and over the history we have for it it has declined 54.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1956 per EA
All-time high$0.4860 (Aug 14, 2019)
All-time low$0.1278 (Nov 20, 2024)
52-week high$0.1956
52-week low$0.1538
Median price$0.2848
Average price$0.2884
Largest weekly change-32.1% (Nov 20, 2024)
Weeks tracked384
Tracking sinceJul 10, 2019

Price History

1W

0.0%

1M

+2.5%

3M

+1.2%

6M

+18.1%

1Y

+25.8%

3Y

-22.8%

5Y

-39.7%

All

-54.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of JASMIEL 3 MG-0.02 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for JASMIEL 3 MG-0.02 MG TABLET, manufactured by Afaxys Pharma, LLC, is $0.1956 per EA (NDC 50102024023), effective Nov 11, 2026.

How has the price of JASMIEL 3 MG-0.02 MG TABLET changed over time?

Over the history we have for it, the NADAC for JASMIEL 3 MG-0.02 MG TABLET has declined 54.3%. It has been tracked across 384 weekly CMS publications since Jul 10, 2019.

What are the highest and lowest recorded NADAC prices for JASMIEL 3 MG-0.02 MG TABLET?

Since Jul 10, 2019, the NADAC for JASMIEL 3 MG-0.02 MG TABLET has ranged from a low of $0.1278 (Nov 20, 2024) to a high of $0.4860 (Aug 14, 2019), with a median of $0.2848 per EA.

Are there cheaper alternatives to JASMIEL 3 MG-0.02 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZUMANDIMINE 3 MG-0.03 MG TAB, is $0.1591 per EA — about 19% below JASMIEL 3 MG-0.02 MG TABLET.

Who manufactures JASMIEL 3 MG-0.02 MG TABLET?

JASMIEL 3 MG-0.02 MG TABLET (NDC 50102024023) is labeled by Afaxys Pharma, LLC, and CMS classifies it as a generic product.